| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pathophysiology (L.P., F.S.), School of Medicine, Comenius University, Bratislava, Slovak Republic; Institute of Normal and Pathological Physiology (L.P.), Slovak Academy of Sciences, Bratislava, Slovak Republic; and the 3rd Clinic of Medicine (F.S.), School of Medicine, Comenius University, Bratislava, Slovak Republic. * To whom correspondence should be addressed. E-mail: ludo{at}lfuk.sk.
Related Article:
LA419, a Novel Nitric Oxide Donor, Prevents Cardiac Remodeling Via the Endothelial Nitric Oxide Synthase Pathway NO Donors as a Means of Antiremodeling
Ludovit Paulis* and Fedor Simko
Hypertension 2007 50: 1049-1056.
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |